Drug substance

Drug substance
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

A drug substance, also known as an active pharmaceutical ingredient (API), is the component of a pharmaceutical drug that produces the intended effects. Drug substances are the biologically active components that are responsible for the therapeutic effects of the drug product.

Definition

A drug substance is defined as any substance or mixture of substances intended to be used in the manufacture of a medicinal product and that, when used in the production of a drug, becomes an active ingredient of the drug product. These substances are intended to furnish pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body.

Classification

Drug substances can be classified based on their origin, chemical structure, or mechanism of action. The main categories include:

• Small molecules: These are low molecular weight compounds that are typically synthesized through chemical processes. They are often administered orally and can easily penetrate cell membranes.

• Biologics: These are larger, complex molecules derived from living organisms. They include proteins, antibodies, and vaccines. Biologics are usually administered via injection.

• Natural products: These are substances derived from natural sources such as plants, animals, or minerals. Examples include morphine from the opium poppy and quinine from the cinchona tree.

Manufacturing

The manufacturing of drug substances involves several critical steps, including:

• Synthesis: For small molecules, this involves chemical synthesis, which may include multiple steps of chemical reactions, purification, and crystallization.

• Fermentation: For biologics, fermentation processes using microorganisms or cell cultures are common. This involves growing the cells in controlled environments to produce the desired protein or antibody.

• Isolation and purification: After synthesis or fermentation, the drug substance must be isolated and purified to remove impurities and ensure the desired level of purity and potency.

• Characterization: The drug substance is characterized using various analytical techniques to determine its chemical structure, purity, and potency. Techniques include mass spectrometry, nuclear magnetic resonance (NMR), and high-performance liquid chromatography (HPLC).

Regulatory Aspects

Drug substances are subject to stringent regulatory requirements to ensure their safety, efficacy, and quality. Regulatory agencies such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe oversee the approval and monitoring of drug substances.

• Good Manufacturing Practice (GMP): Drug substances must be manufactured in compliance with GMP regulations, which ensure that products are consistently produced and controlled according to quality standards.

• Documentation: Detailed documentation is required for the manufacturing process, quality control, and stability testing of drug substances.

• Stability testing: Drug substances must undergo stability testing to determine their shelf life and storage conditions.

Applications

Drug substances are used in a wide range of therapeutic areas, including:

• Oncology: Many anticancer drugs are small molecules or biologics that target specific pathways involved in cancer cell growth.

• Cardiology: Drug substances such as beta-blockers and ACE inhibitors are used to treat cardiovascular diseases.

• Infectious diseases: Antibiotics and antivirals are drug substances used to treat bacterial and viral infections.

Challenges

The development and manufacturing of drug substances present several challenges, including:

• Complexity of biologics: The production of biologics is more complex than small molecules, requiring advanced technology and expertise.

• Regulatory hurdles: Meeting the regulatory requirements for drug substances can be time-consuming and costly.

• Intellectual property: Protecting the intellectual property of drug substances is crucial for pharmaceutical companies to maintain market exclusivity.

Conclusion

Drug substances are the cornerstone of modern medicine, providing the active components necessary for the treatment and prevention of diseases. The development, manufacturing, and regulation of these substances are critical to ensuring the safety and efficacy of pharmaceutical products.